Panadiplon

This classification denotes an anxiolytic with the molecular formula C18H17N5O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V4PW0S7ZP7, chemically known as 3-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)-5-isopropylimidazo(1,5-a)quinoxalin-4(5h)-one but generally known as panadiplon, which bears US NIH Compound Identifier 3033821. European Medicines Agency schedules Panadiplon in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09600MIG. The term PANADIPLON is an International Non-Proprietary Name. PANADIPLON is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule panadiplon under HS 29349990 and SITC 51579. As of Q4 2014, PANADIPLON remains the US FDA Preferred Term for this commodity. Panadiplon bears US NLM identifiers UMLS ID C0287155 and NCI Concept Code C74185. SMILES: O1NC(NC1C1CC1)C1NCN2C1C(=O)N(C(C)C)C1C2CCCC1.